Mannitol Aguettant

Mannitol, the active ingredient in Mannitol Aguettant, is an osmotic diuretic presented as a intravenous solution for intravenous use. It reduces intracranial pressure, treats cerebral edema, acute glaucoma and provides renal protection during nephrotoxic procedures.

GNH USA supplies Mannitol Aguettant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

Mannitol is used in clinical settings to manage conditions involving excess fluid accumulation or elevated pressure within the central nervous system and eye. - Reduction of intracranial pressure: lowers pressure in patients with traumatic brain injury or stroke. - Treatment of cerebral edema: facilitates removal of excess fluid from brain tissue. - Acute glaucoma: decreases intraocular pressure during emergency episodes. - Renal protection during nephrotoxic procedures: helps mitigate kidney injury risk.

Mannitol may cause a range of adverse reactions, from mild to severe, depending on patient factors and dosage.

Common Side Effects: - Electrolyte imbalance: disturbances in sodium or potassium levels. - Dehydration: excessive fluid loss leading to reduced plasma volume. - Hypotension: drop in blood pressure due to rapid diuresis.

Serious or Rare Side Effects: - Pulmonary edema: fluid accumulation in the lungs. - Seizures: neurological events linked to rapid osmotic shifts. - Anaphylactic reaction: severe allergic response requiring immediate medical attention.

When using Mannitol, clinicians should observe several safety measures to minimize risks. - Renal function: monitor serum creatinine and urine output. - Cardiovascular status: watch for hypotension and adjust infusion rate. - Electrolyte levels: regularly check sodium and potassium concentrations. - Pregnancy: use only if potential benefits outweigh potential risks. - Store at ambient temperature: keep in original container, protect from light and moisture.

Mannitol can interact with other medications, influencing fluid and electrolyte balance.

Major Interactions (Avoid): - Loop diuretics: may cause excessive fluid loss and electrolyte disturbances. - Insulin: can potentiate hypoglycemia when combined with rapid fluid shifts. - ACE inhibitors: increase risk of profound hypotension.

Moderate Interactions (Monitor Closely): - Antihypertensives: may enhance blood pressure‑lowering effects. - Lithium: may raise serum lithium levels, requiring dose adjustment.